Katarzyna Kubica

Dr. Katarzyna Kubica

Chemistry, Jagiellonian University, Kraków, Małopolskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ARAtilio Reyes Romero
Atilio Reyes Romero
KKKatarzyna Kubica
Katarzyna Kubica
RKRadoslaw Kitel
Radoslaw Kitel
IRIsmael Alejandro Rodriguez
Ismael Alejandro Rodriguez
KMKatarzyna Magiera-Mularz
Katarzyna Magiera-Mularz
ESEwa Surmiak
Ewa Surmiak
By binding to the spliceosomal protein Snu66, the human ubiquitin-like protein Hub1 is a modulator of the spliceosome performance and facilitates alternative splicing. Small molecules that bind to Hub1 would be of interest to study the protein-protein interaction of Hub1/Snu66, which is linked to several human pathologies, such as hypercholesterolemia, premature aging, neurodegenerative diseases, and cancer. To identify small molecule ligands for Hub1, we used the interface analysis, peptide modeling of the Hub1/Snu66 interaction and the fragment-based NMR screening. Fragment-based NMR screening has not proven sufficient to unambiguously search for fragments that bind to the Hub1 protein. This was because the Snu66 binding pocket of Hub1 is occupied by pH-sensitive residues, making it difficult to distinguish between pH-induced NMR shifts and actual binding events. The NMR analyses were therefore verified experimentally by microscale thermophoresis and by NMR pH titration experiments. Our study found two small peptides that showed binding to Hub1. These peptides are the first small-molecule ligands reported to interact with the Hub1 protein.